{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T16:55:02Z","timestamp":1769532902021,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jocn.2019.04.011","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T17:53:39Z","timestamp":1556128419000},"page":"269-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Chronic myeloid leukemia manifested as myeloid sarcoma: Review of literature and case report"],"prefix":"10.1016","volume":"64","author":[{"given":"Ali H.","family":"Palejwala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle P.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Scordino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad A.","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jocn.2019.04.011_b0005","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1182\/blood-2008-02-140665","article-title":"Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia","volume":"112","author":"Porkka","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jocn.2019.04.011_b0010","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1182\/blood-2002-10-3059","article-title":"The CNS is a sanctuary for leukemic cells in mice receiving imatinib mesylate for Bcr\/Abl-induced leukemia","volume":"101","author":"Wolff","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jocn.2019.04.011_b0015","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11060-017-2541-6","article-title":"Intracranial granulocytic sarcoma as the first presentation of chronic myeloid leukemia in chronic phase","volume":"134","author":"Kabadi","year":"2017","journal-title":"J Neurooncol"},{"issue":"24","key":"10.1016\/j.jocn.2019.04.011_b0020","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1200\/JCO.2006.05.5608","article-title":"Isolated blast crisis in CNS in a patient with chronic myelogenous leukemia maintaining major cytogenetic response after imatinib","volume":"24","author":"Kim","year":"2006","journal-title":"J Clin Oncol: Offic J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2019.04.011_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2257.2006.00782.x","article-title":"Extramedullary blast crises in CML patients in complete hematological remission treated with imatinib mesylate","volume":"28","author":"Simpson","year":"2006","journal-title":"Clin Lab Haematol"},{"issue":"22","key":"10.1016\/j.jocn.2019.04.011_b0030","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1200\/JCO.2003.99.170","article-title":"CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: two case reports","volume":"21","author":"Abruzzese","year":"2003","journal-title":"J Clin Oncol: Offic J Am Soc Clin Oncol"},{"issue":"2","key":"10.1016\/j.jocn.2019.04.011_b0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000447711","article-title":"An atypical initial presentation of chronic myeloid leukemia with central nervous system and lymph node blast crises","volume":"9","author":"Abuelgasim","year":"2016","journal-title":"Case Rep Oncol"},{"issue":"11","key":"10.1016\/j.jocn.2019.04.011_b0040","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1016\/j.leukres.2009.04.023","article-title":"Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: case report and review of the literature","volume":"33","author":"Aftimos","year":"2009","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.jocn.2019.04.011_b0045","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2362.2007.01859.x","article-title":"Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy","volume":"37","author":"Aichberger","year":"2007","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.jocn.2019.04.011_b0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11060-007-9352-0","article-title":"Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report","volume":"84","author":"Altintas","year":"2007","journal-title":"J Neurooncol"},{"issue":"3","key":"10.1016\/j.jocn.2019.04.011_b0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2141.2008.07136.x","article-title":"Isolated central nervous system lymphoid blast crisis in chronic myeloid leukaemia in major molecular remission","volume":"142","author":"Barlow","year":"2008","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jocn.2019.04.011_b0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00277-003-0829-4","article-title":"CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid","volume":"83","author":"Bornhauser","year":"2004","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.jocn.2019.04.011_b0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/10428190310001593184","article-title":"Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy","volume":"45","author":"Bujassoum","year":"2004","journal-title":"Leukem Lymp"},{"key":"10.1016\/j.jocn.2019.04.011_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s12185-018-2511-6","article-title":"Chronic myelogenous leukemia presenting with central nervous system infiltration, successfully treated with central nervous system-directed chemotherapy followed by allogeneic stem cell transplantation","author":"Chiba","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jocn.2019.04.011_b0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2326-12-9","article-title":"Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Fuchs","year":"2012","journal-title":"BMC Blood Disorder"},{"key":"10.1016\/j.jocn.2019.04.011_b0080","series-title":"In vivo (Athens, Greece)","first-page":"1149","article-title":"Isolated central nervous system relapse in two patients with BCR-ABL-positive acute leukemia while receiving a next-generation tyrosine kinase inhibitor","author":"Gaur","year":"2014"},{"key":"10.1016\/j.jocn.2019.04.011_b0085","doi-asserted-by":"crossref","first-page":"232915","DOI":"10.1155\/2015\/232915","article-title":"Isolated central nervous system relapse in chronic myeloid leukemia","volume":"2015","author":"Gomez","year":"2015","journal-title":"Case Rep Med"},{"key":"10.1016\/j.jocn.2019.04.011_b0090","series-title":"Internal medicine (Tokyo, Japan)","first-page":"3341","article-title":"A Rare Monocytic Crisis of Chronic Myelogenous Leukemia Presenting with Unusual Extramedullary Manifestations and an Atypical (14;22)(q24;q11.2) Translocation in the Bone Marrow","author":"Inoue","year":"2017"},{"issue":"6","key":"10.1016\/j.jocn.2019.04.011_b0095","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1445-5994.2009.01947.x","article-title":"Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate","volume":"39","author":"Isobe","year":"2009","journal-title":"Int Med J"},{"issue":"1","key":"10.1016\/j.jocn.2019.04.011_b0100","article-title":"Isolated CNS blast crises in chronic myeloid leukaemia presenting as hypertrophic pachymeningitis and bilateral optic neuritis: a case report","volume":"10","author":"Jain","year":"2016","journal-title":"J Clin Diagn Res: JCDR"},{"issue":"4","key":"10.1016\/j.jocn.2019.04.011_b0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/10428190400025120","article-title":"Isolated central nervous system relapse in patients with chronic myeloid leukemia on imatinib mesylate","volume":"46","author":"Johnson","year":"2005","journal-title":"Leukem Lymph"},{"issue":"7","key":"10.1016\/j.jocn.2019.04.011_b0110","doi-asserted-by":"crossref","first-page":"745","DOI":"10.6004\/jnccn.2013.0097","article-title":"An unusual presentation of chronic myelogenous leukemia: a review of isolated central nervous system relapse","volume":"11","author":"Lindhorst","year":"2013","journal-title":"J Nat Compreh Cancer Netw: JNCCN"},{"issue":"4","key":"10.1016\/j.jocn.2019.04.011_b0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1532\/IJH97.04188","article-title":"Extramedullary blast crisis derived from 2 different clones in the central nervous system and neck during complete cytogenetic remission of chronic myelogenous leukemia treated with imatinib mesylate","volume":"81","author":"Matsuda","year":"2005","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.jocn.2019.04.011_b0120","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/mpo.1146","article-title":"Unusual cause of extradural haemorrhage","volume":"36","author":"McCabe","year":"2001","journal-title":"Med Pediatr Oncol"},{"issue":"8","key":"10.1016\/j.jocn.2019.04.011_b0125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00277-011-1171-x","article-title":"Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation","volume":"90","author":"Neumann","year":"2011","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.jocn.2019.04.011_b0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000347158","article-title":"Dasatinib maintenance therapy after allogeneic hematopoietic stem cell transplantation for an isolated central nervous system blast crisis in chronic myelogenous leukemia","volume":"130","author":"Nishimoto","year":"2013","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.jocn.2019.04.011_b0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3343\/alm.2014.34.3.247","article-title":"A case of isolated lymphoblastic relapse of the central nervous system in a patient with chronic myelogenous leukemia treated with imatinib","volume":"34","author":"Park","year":"2014","journal-title":"Ann Lab Med"},{"issue":"3","key":"10.1016\/j.jocn.2019.04.011_b0140","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2141.2002.03523.x","article-title":"Low concentrations of STI571 in the cerebrospinal fluid: a case report","volume":"117","author":"Petzer","year":"2002","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jocn.2019.04.011_b0145","first-page":"777","article-title":"Dural metastases in chronic myeloid leukemia presenting as subdural hematoma","volume":"22","author":"Prasad","year":"2012","journal-title":"Turkish Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2019.04.011_b0150","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12288-011-0055-5","article-title":"Central nervous system blast crisis in chronic myeloid leukemia on imatinib mesylate therapy: report of two cases","volume":"27","author":"Radhika","year":"2011","journal-title":"Indian J Hematol Blood Transf: Offic J Indian Soc Hematol Blood Transf"},{"issue":"4","key":"10.1016\/j.jocn.2019.04.011_b0155","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hon.737","article-title":"Isolated central nervous system blast crisis in chronic myeloid leukemia","volume":"22","author":"Rajappa","year":"2004","journal-title":"Hematol Oncol"},{"issue":"4","key":"10.1016\/j.jocn.2019.04.011_b0160","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.leukres.2009.09.022","article-title":"Isolated CNS relapse of CML after bone marrow transplantation","volume":"34","author":"Thomas","year":"2010","journal-title":"Leuk Res"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818321763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586818321763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:18:08Z","timestamp":1760822288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586818321763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":32,"alternative-id":["S0967586818321763"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2019.04.011","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic myeloid leukemia manifested as myeloid sarcoma: Review of literature and case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2019.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}